drugset / Trial / NCT00054964

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

NCT00054964

Phase 2 Completed 14 enrolled Teva Branded Pharmaceutical Products R&D, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This study was designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.

Timeline

Start
2003-03-31
Primary completion
2003-08-31
Completion
2003-08-31

Publications

  • Results Nelson HS, Wenzel SE, Weisfeld L, Llorens L, Atkinson DC, Stahl EG. Comparison of single-dose efficacy of albuterol-hydrofloroalkane breath-activated inhaler and Nelson HS, Wenzel SE, Weisfeld L, Llorens L, Atkinson DC, Stahl EG. Comparison of single-dose efficacy of albuterol-hydrofloroalkane metered-dose inhaler in asthma patients with poor inhaler coordinating ability. Chest 2008;134:92003S (Abstracts, ACCP Annual Meeting, October 25-30, 2008, Philadelphia, Pennsylvania, USA.

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salbutamol Unknown 90 ug
Comparator Salbutamol Unknown

Indications